Clinical TrialsSearch results
Number of results: 279
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- study of Helicobacter pylori Eradication after endoscopic resection of early gastric cancer
- early stage of gastric cancer
- Japan Gast Study Group
- 2008-05-31
Other
- Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial
- Outpatients who are required a combination therapy with sitting systolic blood pressure >=140 mmHg or diastolic blood pressure>=90 mmHg
- COPE Trial Group
- 2008-05-12
Other
- A prospective observation study concerning the incidence of atherothrombotic events in patients with acute coronary syndrome.
- Acute coronary syndrome
- Sanofi K.K.
- 2008-05-10
Other
- Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and daunorubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia.
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2008-05-10
Other
- A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)
- malignant renal tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-04-22
Other
- JPLT2 protocol (CITA and ITEC regimen)for the pediatric liver tumor in Japan
- hepatoblastoma hepatocellular carcinoma
- Japanese Study Group for Pediatric Liver Tumors
- 2008-04-09
Other
- Analysis of Circulating Progenior Cells and Endothelial Function
- arteriosclerosis, coronary heart disease, peripheral artery disease, organ taransplantation, hypertension
- Nagoya University
- 2008-04-01
Other
- Randomized Phase III Study of Adjuvant Endocrine-Therapy with or without Chemotherapy for Postmenopausal Breast Cancer Patients who Responded to Neoadjuvant Letrozole
- postmenopausal primary breast cancer
- NEOS executive committee
- 2008-03-20
Other
- Safety and Immunogenicity of Cholesterol-Bearing Hydrophobized Pullulan HER2 Protein 146 (CHP-HER2) and NY-ESO-1 Protein (CHP-NY-ESO-1) in Combination With OK-432 in HER2- and/or NY-ESO-1-Expressing Cancers
- Esophageal Cancer, Lung Cancer, Stomach Cancer, Breast Cancer, Ovarian Cancer
- Mie University Graduate School of Medicine, Kitano Hospital
- 2008-03-16